Bimectin Vet.
Summary of the Product Characteristics
Name of the Veterinary Medicinal Product
Bimectin vet. 10 mg/ml, solution for injection
Qualitative and Quantitative Composition
Active substance(s)
1 ml contains:
Ivermectin 10 mg
For a full list of excipients, see section 6.1
Pharmaceutical Form
Solution for injection.
Clear colourless to slightly yellow coloured solution.
4. Clinical Particulars
4.1 Target species
Cattle, reindeer and pigs.
4.2 Indications for use, specifying the target species
Bimectin vet. Injection is indicated for treatment of the following parasites of cattle, reindeer and pigs.
Cattle:
Gastro-intestinal roundworms(adult and fourth stage larvae, L4)
Ostertagia ostertagi.(including inhibited L4)
Ostertagia lyrata
Haemonochus placei
Trichostrongylus axei
Trichostrongylus colubriformis (L4)
Cooperia spp.
Oesophagostomum radiatum
Nematodirus spathiger(adult)
Lungworms (adult and fourth stage larvae, L4)
Dictyocaulus viviparus.
Warbles (larval stages)
Hypoderma bovis
Hypoderma lineatum.
Mange mites
Sarcoptes scabiei var. bovis
Psoroptes bovis
Lice
Linognathus vituli
Haematopinus eurysternus
Reindeer
Larval stages of Hypoderma tarandi.
Pigs:
Gastro-intestinal roundworms(adult and fourth stage larvae, L4)
Ascaris suum
Hyostrongylus rubidus
Oesophagostomum spp.
Strongyloides ransomi (adult)
Lungworms
Metastrongylus spp. (adult)
Mange mites
Sarcoptes scabiei var. suis
Lice
Haematopinus suis
4.3 Contraindications
Should not be given to animals with known hypersensitivity to ivermectin.
Special Warnings for each target
species
Neonatal pigs are sensitive for
overdosage of ivermectin, presumably due to a more permeable
blood-brain barrier. Piglets
< 5 days should not be treated.
Special precautions for use
Special
precautions for use in animals
Avermectins/Melbecycins may not be
well tolerated in all non-target species (cases of intolerance with
fatal outcome are reported in dogs especially Collies, Old English
Sheepdogs and related breeds or crosses, and also in
turtles/tortoises).
Special precautions to be taken by the person
administering the veterinary medicinal product to
animals
None specific.
Adverse
reactions (frequency and seriousness)
Local reaction at the injection site
may occur.
Use during
pregnancy and lactation
Bimectin vet. Injection can be
administered to beef cows and pigs at any stage of pregnancy or
lactation. Bimectin vet. Injection should not be given to lactating
cows, or heifers and dry cows within 60 days prior to calving, when
the milk is intended for human consumption.
Interaction with other medicinal
products and other forms of interaction
None known.
Amounts to be
administered and administration routes
Bimectin vet. Injection should be
given by subcutaneous injection.
Cattle and reindeer:
1 ml of Bimectin vet. Injection per 50 kg
bodyweight, corresponding to 0.2 mg ivermectin per kg
bodyweight.
Pigs: 1 ml of Bimectin vet. Injection per 33 kg bodyweight,
corresponding to 0.3 mg ivermectin per kg bodyweight.
4.10 Overdose (symptoms, emergency procedures, antidotes), if
necessary
Severe overdose (4-30 mg/kg) can lead
to lethargy, ataxia and tremor.
4.11 Withdrawal Periods
Slaughter: Cattle 49 days, reindeer and pigs 28 days.
Lactating cows producing milk
for human consumption should not be treated. Dry cows and heifers
should not be treated within 60 days prior to calving.
5. Pharmacological Properties
Pharmacotherapeutic group: Endectocides
ATC vet code: QP54AA01
5.1 Pharmacodynamic properties
Ivermectin is a member of the macrocyclic lactone class of endectocides, which can bind selectively to glutamate-gated chloride ion channels that occur in several invertebrate nerve and muscle cells. This leads to an increase in the permeability of the cell membrane to chloride ions with hyperpolarization of the nerve and muscle cell, resulting in paralysis and death of the parasite. Compounds of this class may also interact with other ligand-gated chloride channels, such as those gated by the neurotransmitter gamma-aminobutyric acid (GABA).
The margin of safety for compounds of this class is attributable to the fact that mammals do not have glutamate-gated chloride channels. In addition, the macrocyclic lactones have a low affinity for other mammalian ligand-gated chloride channels and they do not readily cross the blood-brain barrier in normal conditions.
5.2 Pharmacokinetic particulars
Maximum plasma concentration in cattle is reached on average in 5,5 days and in pigs in 3,5 days after administration. The mean elimination half-life is 6 days in cattle and 5,5 days in pigs. Ivermectin is distributed to tissues in the following order: liver > fat > kidney > muscle in cattle and fat > liver > kidney > muscle in pigs. The substance is only partially metabolised. Unmetabolised ivermectin and degradation products are excreted to about 98 % in faeces and 2 % in urine.
Pharmaceutical Particulars
List of excipients
Glycerol
Glycerol formal (contains thiopropionic acid, N-propyl gallate and disodium
edetate)
Major incompatibilities
Due to lack of incompatibility studies, this veterinary medicinal drug should not be mixed with other veterinary medicinal drugs.
Shelf life
2 years.
After first opening, the product should be used within 28 days.
Special precautions for storage
Keep the container in the outer carton, in order to protect from light.
Nature and composition of immediate packaging
Vials of polyethylene sealed with bromobutyl stoppers and aluminium overseals in cartons.
-
-
Packaging sizes:
1 x 50 ml
1 x 250 ml
1 x 6 x 250 ml
1 x 500 ml
-
Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from such medicinal products
Free ivermectin is very toxic to fish and other water-borne organisms. Residual drug must be handed in to the pharamacy for destruction.
Marketing Authorisation Holder
Bimeda (Cross vetpharm Group Ltd.)
Broomhill Road
Tallaght
Dublin 24
Irland
Marketing Authorisation
Number(s)
15652
Date of First Authorisation/Renewal of the Authorisation
2001-03-09/2006-03-09
Date of Revision of the Text
2009-10-01
6